Publication | Closed Access
Use of Dibutyl[<sup>14</sup>C]formamide as a Formylating Reagent in the <i>Vilsmeier</i>–<i>Haack</i> Reaction and Synthesis of a <sup>14</sup>C‐Labeled Novel Phosphodiesterase‐4 (PDE‐4) Inhibitor
23
Citations
7
References
2005
Year
Medicinal ChemistryBioorganic ChemistryScheme 1BiochemistryNatural SciencesMedicineDiversity-oriented SynthesisH 14Co 2Peptide SynthesisOrganic ChemistryFormylating ReagentDrug DevelopmentPharmacologyPharmaceutical ChemistrySynthetic ChemistryBiomolecular EngineeringDrug Discovery
Abstract A simple, high‐yielding synthesis of dibutyl[ 14 C]formamide ([ 14 C]DBF; 1 ) from 14 CO 2 was developed ( Scheme 1 ): reaction of LiBEt 3 H and 14 CO 2 followed by aqueous workup gave H 14 CO 2 H in high yield. Conversion of the [ 14 C]formic acid to 1 was effected by a standard carbodiimide coupling procedure. The utility of 1 as an alternative to dimethyl[ 14 C]formamide ([ 14 C]DMF) in alkylation reactions and in the [ 14 C] Vilsmeier–Haack reaction was demonstrated for several substrates ( Table 2 ). A 14 C‐labeled phosphodiesterase‐4 (PDE‐4) inhibitor, [ 14 C]‐ 2 , was synthesized by application of this technology ( Scheme 2 ).
| Year | Citations | |
|---|---|---|
Page 1
Page 1